The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer

被引:38
作者
Kidane, Biniam [1 ]
Bott, Matthew [2 ]
Spicer, Jonathan [3 ]
Backhus, Leah [4 ]
Chaft, Jamie [2 ]
Chudgar, Neel [5 ]
Colson, Yolonda [6 ]
DAmico, Thomas A. [7 ]
David, Elizabeth [8 ]
Lee, Jay [9 ]
Najmeh, Sara [3 ]
Sepesi, Boris [10 ]
Shu, Catherine [11 ]
Yang, Jeffrey [6 ]
Swanson, Scott [12 ]
Stiles, Brendon [5 ,13 ]
机构
[1] Univ Manitoba, Winnipeg, MB, Canada
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] McGill Univ, Montreal, PQ, Canada
[4] Stanford Univ, Palo Alto, CA USA
[5] Albert Einstein Coll Med, Bronx, NY USA
[6] Massachusetts Gen Hosp, Boston, MA USA
[7] Duke Canc Inst, Durham, NC USA
[8] Univ Colorado, Denver, CO USA
[9] Univ Calif Los Angeles, Los Angeles, CA USA
[10] MD Anderson Canc Ctr, Houston, TX USA
[11] Columbia Univ, New York, NY USA
[12] Brigham & Womens Hosp, Boston, MA USA
[13] Montefiore Med Ctr, Div Thorac Surg, 111 East 210th St, Bronx, NY 10467 USA
关键词
clinical staging; neoadjuvant; adjuvant; immunotherapy; targeted therapy; surgery; non-small cell lung cancer; LYMPH-NODE DISSECTION; TRANSBRONCHIAL NEEDLE ASPIRATION; RESIDUAL TUMOR DESCRIPTORS; CHEMOTHERAPY PLUS SURGERY; ADJUVANT CHEMOTHERAPY; INTERNATIONAL ASSOCIATION; ENDOBRONCHIAL ULTRASOUND; SURGICAL RESECTION; RANDOMIZED-TRIAL; INDUCTION CHEMORADIATION;
D O I
10.1016/j.jtcvs.2023.04.039
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Novel targeted therapy and immunotherapy drugs have recently been approved for use in patients with surgically resectable lung cancer. Accurate staging, early molecular testing, and knowledge of recent trials are critical to optimize oncologic outcomes in these patients.
引用
收藏
页码:637 / 654
页数:18
相关论文
共 149 条
[1]   Lobe-Specific Lymph Node Dissection as a Standard Procedure in Surgery for Non-Small Cell Lung Cancer: A Propensity Score Matching Study [J].
Adachi, Hiroyuki ;
Sakamaki, Kentaro ;
Nishii, Teppei ;
Yamamoto, Taketsugu ;
Nagashima, Takuya ;
Ishikawa, Yoshihiro ;
Ando, Kohei ;
Yamanaka, Kazuki ;
Watanabe, Katsuya ;
Kumakiri, Yutaka ;
Tsuboi, Masahiro ;
Maehara, Takamitsu ;
Nakayama, Haruhiko ;
Masuda, Munetaka .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) :85-93
[2]  
Ak N, 2021, J BUON, V26, P819
[3]   Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial [J].
Albain, Kathy S. ;
Swann, R. Suzanne ;
Rusch, Valerie W. ;
Turrisi, Andrew T., III ;
Shepherd, Frances A. ;
Smith, Colum ;
Chen, Yuhchyau ;
Livingston, Robert B. ;
Feins, Richard H. ;
Gandara, David R. ;
Fry, Willard A. ;
Darling, Gail ;
Johnson, David H. ;
Green, Mark R. ;
Miller, Robert C. ;
Ley, Joanne ;
Sause, Willliam T. ;
Cox, James D. .
LANCET, 2009, 374 (9687) :379-386
[4]   Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503) [J].
Altorki, Nasser K. ;
Wang, Xiaofei ;
Wigle, Dennis ;
Gu, Lin ;
Darling, Gail ;
Ashrafi, Ahmad S. ;
Landrenau, Rodney ;
Miller, Daniel ;
Liberman, Moishe ;
Jones, David R. ;
Keenan, Robert ;
Conti, Massimo ;
Wright, Gavin ;
Veit, Linda J. ;
Ramalingam, Suresh S. ;
Kamel, Mohamed ;
Pass, Harvey I. ;
Mitchell, John D. ;
Stinchcombe, Thomas ;
Vokes, Everett ;
Kohman, Leslie J. .
LANCET RESPIRATORY MEDICINE, 2018, 6 (12) :915-924
[5]   Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules [J].
Altorki, Nasser K. ;
Yip, Rowena ;
Hanaoka, Takaomi ;
Bauer, Thomas ;
Aye, Ralph ;
Kohman, Leslie ;
Sheppard, Barry ;
Thurer, Richard ;
Andaz, Shahriyour ;
Smith, Michael ;
Mayfield, William ;
Grannis, Fred ;
Korst, Robert ;
Pass, Harvey ;
Straznicka, Michaela ;
Flores, Raja ;
Henschke, Claudia I. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 147 (02) :754-762
[6]  
[Anonymous], 2022, Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer
[7]   Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC [J].
Antonia, S. J. ;
Villegas, A. ;
Daniel, D. ;
Vicente, D. ;
Murakami, S. ;
Hui, R. ;
Kurata, T. ;
Chiappori, A. ;
Lee, K. H. ;
de Wit, M. ;
Cho, B. C. ;
Bourhaba, M. ;
Quantin, X. ;
Tokito, T. ;
Mekhail, T. ;
Planchard, D. ;
Kim, Y. -C. ;
Karapetis, C. S. ;
Hiret, S. ;
Ostoros, G. ;
Kubota, K. ;
Gray, J. E. ;
Paz-Ares, L. ;
Carpeno, J. de Castro ;
Faivre-Finn, C. ;
Reck, M. ;
Vansteenkiste, J. ;
Spigel, D. R. ;
Wadsworth, C. ;
Melillo, G. ;
Taboada, M. ;
Dennis, P. A. ;
Ozguroglu, M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (24) :2342-2350
[8]   Radiographically determined noninvasive adenocarcinoma of the lung: Survival outcomes of Japan Clinical Oncology Group 0201 [J].
Asamura, Hisao ;
Hishida, Tomoyuki ;
Suzuki, Kenji ;
Koike, Teruaki ;
Nakamura, Kenichi ;
Kusumoto, Masahiko ;
Nagai, Kanji ;
Tada, Hirohito ;
Mitsudomi, Tetsuya ;
Tsuboi, Masahiro ;
Shibata, Taro ;
Fukuda, Haruhiko .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 146 (01) :24-30
[9]   The American Association for Thoracic Surgery/Society of Thoracic Surgeons position statement on developing clinical practice documents [J].
Bakaeen, Faisal G. ;
Svensson, Lars G. ;
Mitchell, John D. ;
Keshavjee, Shaf ;
Patterson, G. Alexander ;
Weisel, Richard D. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2017, 153 (04) :999-1005
[10]   Cardiac Toxicity of Thoracic Radiotherapy: Existing Evidence and Future Directions [J].
Banfill, Kathryn ;
Giuliani, Meredith ;
Aznar, Marianne ;
Franks, Kevin ;
McWilliam, Alan ;
Schmitt, Matthias ;
Sun, Fei ;
Vozenin, Marie Catherine ;
Finn, Corinne Faivre .
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (02) :216-227